Thrombin inhibits adenylate cyclase and stimulates GTP hydrolysis by high-affinity GTPase(s) in membranes of human platelets at almost identical concentrations. Both of these thrombin actions are similar to those observed with agonist-activated cz2-adrenoceptors coupling to the inhibitory guanine nucleotide-binding protein N1. However, stimulation of GTP hydrolysis caused by adrenaline (a2-adrenoceptor agonist) and by thrombin at maximally effective concentrations was partially additive, whereas with regard to adenylate cyclase inhibition no additive response was observed. Furthermore, treatment of platelet membranes with pertussis toxin, which inactivates Ni and largely abolishes thrombin-and adrenaline-induced adenylate cyclase inhibition and adrenaline-induced GTPase stimulation, decreased the thrombin-induced stimulation of GTP hydrolysis by only about 30%. Additionally, the thiol reagent N-ethylmaleimide (NEM) at rather low concentrations abolished thrombin-and adrenaline-induced adenylate cyclase inhibition and adrenalineinduced GTPase stimulation. In contrast, the thrombin-induced stimulation of GTP hydrolysis was decreased by only 30-40% by treatment of platelet membranes with even high concentrations of NEM.
INTRODUCTION
We previously described that thrombin is a potent and efficient inhibitor of the adenylate cyclase in human platelet membranes (Aktories & Jakobs, 1984) . This thrombin action is apparently mediated by the inhibitory guanine nucleotide-binding protein Ni, since the inhibition is GTP-dependent and since it can be inhibited by treatment of platelet membranes with pertussis toxin and N-ethylmaleimide (NEM), similar to the action of adrenaline causing adenylate cyclase inhibition via a2-adrenoceptors (Jakobs et al., 1982; Aktories et al., 1983) . Furthermore, similar to adrenaline, thrombininduced inhibition of adenylate cyclase was accompanied by an increased GTP hydrolysis by a high-affinity GTPase(s) . Both reactions, inhibition of adenylate cyclase and stimulation of GTP hydrolysis, were observed at almost identical concentrations of thrombin (Aktories & Jakobs, 1984) , which suggested that, similar to adrenaline's action (Aktories et al., 1983) , the thrombin stimulation ofhigh-affinity GTPase is an action at Ni.
On the other hand, thrombin is one of the most effective activators of the phosphoinositide breakdown in human platelets, whereas adrenaline is very weak or not active at all in this regard (Agranoff et al., 1983; Siess et al., 1984; Rittenhouse & Sasson, 1985) . Functional studies performed in permeabilized platelets suggested that a guanine nucleotide-binding regulatory protein may also be involved in the thrombin stimulation of phosphoinositide metabolism (Haslam & Davidson, 1984a,b) . Therefore, we re-evaluated the thrombininduced stimulation of GTP hydrolysis in human platelet membranes, to try to resolve a guanine nucleotide-binding protein other than Ni being activated by thrombin. We report here that thrombin activation of GTP hydrolysis by high-affinity GTPase(s) in human platelet membranes can be discriminated from those induced by adrenaline and prostaglandin E1 (PGE1), acting via Ni and N5 respectively, on the platelet adenylate cyclase.
MATERIALS AND METHODS Materials
The agents used were obtained from sources previously described (Jakobs et al., 1982; Aktories et al., 1983; Aktories & Jakobs, 1984) . Preparation and treatment of platelet membranes Membranes of human platelets were prepared as previously described, with 5 mM-EDTA present throughout the membrane preparation procedure (Jakobs et al., 1982) . Treatment of platelet membranes with pertussis Vol. 237 Abbreviations used: Ni and N., the guanine nucleotide regulatory protein that couples inhibitory and stimulatory hormone receptors, respectively, to adenylate cyclase; NEM, N-ethylmaleimide; PGE,, prostaglandin E1. * Present address: Rudolf Buchheim-Institut fur Pharmakologie der Universitat Giessen, D-6300 Giessen, Federal Republic of Germany. toxin was performed as described by Aktories & Jakobs (1984) at a concentration of 50 ,ug of toxin/ml for 30 min at 37 'C. Cholera-toxin treatment was carried out as described by Aktories et al. (1983) , at a concentration of 100 ,tg of toxin/ml for 10 min at 30 'C.
GTPase assay
The reaction mixture contained, if not otherwise indicated, 0.5 5/M-[y-32P]GTP (0.1 ,tCi/tube), 2 mMMgCl2, 0.1 mM-EGTA, 0.1 mM-ATP, 5 mM-phosphocreatine, 0.4 mg of creatine kinase/ml, 2 mg of bovine serum albumin/ml and the additions indicated in 50 mM-triethanolamine/HCl, pH 7.4, in a total volume of 100 ll. When adenylate cyclase and GTPase activities were determined simultaneously (see Figs. 1-3 ), the reaction mixture additionally contained 20 /LM-forskolin, 1 mM-3-isobutyl-1-methylxanthine and 0.1 mM-cyclic AMP. The reaction was started by the addition of platelet membranes (8-15 ,ug of protein/tube) and conducted for 10 min at 25 'C. The reaction was stopped and the released Pi was isolated as described by Aktories et al. (1983) . When the effect of NEM on GTP hydrolysis was studied, the membranes were preincubated with the indicated concentrations of NEM for 15 min at 25 'C in the presence of the complete reaction mixture except for GTP and hormones. This reaction was stopped by the addition ofdithiothreitol at a concentration at least 3-fold higher than the highest NEM concentration used. Thereafter, measurement of GTP hydrolysis was started by the addition of GTP without and with the hormonal factors studied and continued for 10 min at 25 'C. Low-affinity GTPase activity was determined and subtracted from the total GTPase activity by measuring the GTP hydrolysis at 50 /,M-GTP as described by Cassel & Selinger (1976) . Adenylate cyclase assay Adenylate cyclase activity was determined with the identical reaction mixture as described above for GTPase assay, with forskolin, 3-isobutyl-1-methylxanthine and cyclic AMP included, but instead of [y-32P]GTP, [a-32P] ATP (0.2,uCi/tube) was present. Preincubation and incubation conditions were as for GTPase assay. The reaction was stopped and cyclic AMP formed was isolated as described by Jakobs et al. (1976) . Both types of assays were performed in triplicate, with intra-assay variations of less than 300 of the means, and were repeated at least twice, with results comparable with those shown herein.
RESULTS
As reported previously (Aktories & Jakobs, 1984) , thrombin decreased adenylate cyclase activity in membranes of human platelets more efficiently than did adrenaline (Fig. 1) . When thrombin was combined with adrenaline at a maximally effective concentration (100,CM), the effects of both agents were not additive. Similar to adenylate cyclase inhibition, thrombin was more effective than adrenaline in stimulating GTP hydrolysis by high-affinity GTPase(s) in platelet membranes. However, in contrast with adenylate cyclase inhibition, the combined effects of adrenaline and thrombin on GTP hydrolysis were at least partially additive. These data suggested that thrombin activation of GTP hydrolysis in human platelet membranes is GTPase (right ordinate; e, *) were determined in membranes of human platelets in the absence (0, *) and presence of 100l uM-adrenaline ([l, *) at the indicated concentrations of thrombin.
at least in part mediated by a GTPase not affected by agonist-stimulated a2-adrenoceptors. Therefore we studied whether the stimulation of GTP hydrolysis by thrombin is sensitive to agents causing inactivation of Ni.
Treatment of the platelet membranes with pertussis toxin has been shown previously to inhibit considerably GTP hydrolysis caused by adrenaline (Aktories et al., 1983) . However, the thrombin stimulation of GTP hydrolysis was only partially decreased by this treatment (Table 1) . Even at a concentration of 50 ,ug of pertussis toxin/ml, the absolute increase in GTP hydrolysis by high-affinity GTPase caused by thrombin (0.1 unit/ml) was decreased by only 25%, whereas adrenaline (100 /tM)-induced stimulation of GTP hydrolysis was decreased by about Membranes of human platelets were pretreated without (Control) and with 50 ,ug of pertussis toxin/ml for 30 min at 37°C as described by Aktories et al. (1983) . In these membranes, high-affinity GTPase activities were determined without and with 100 ,tM-adrenaline or 0.1 unit of thrombin/ml. The data (means+S.E.M. for three experiments performed in triplicate) are the agonist-induced increase in GTPase activity. Membranes of human platelets were pretreated for 15 min at 25°C with the indicated concentrations of NEM. This reaction was stopped by adding I mM-dithiothreitol.
Thereafter, high-affinity GTPase activity was determined without (0) and with 100 uM-adrenaline (M) or 0.1 unit of thrombin/ml (-).
900% by this treatment, as described previously (Aktories et al., 1983) . Since pertussis toxin does not act on intact platelets , about 1000-fold higher concentrations of the toxin than are usually applied in other intact cell systems had to be used with the platelet membranes.
The other agent that has been shown previously to eliminate Ni-mediated actions in platelet membranes is the thiol reagent NEM (Jakobs et al., 1982; Limbird & Speck, 1983) . This agent additionally inactivates adenylate cyclase, apparently by a direct action at the catalytic moiety. As shown in Fig. 2 Fig. 4 illustrates the concentration/response curves for adrenaline and thrombin stimulation of GTP hydrolysis in control membranes and membranes pre-treated for 15 min at 25°C with 0.1 mM-NEM. In control membranes, thrombin stimulated GTP hydrolysis more efficiently than adrenaline, with half-maximal and maximal increase occurring at about 0.004 and 0.1 unit of thrombin/ml respectively. In NEM-pretreated membranes, the potency of thrombin in stimulating GTP hydrolysis was only slightly lessened. Half-maximal stimulation was observed at 0.006 unit of thrombin/ml. The maximal increase in GTP hydrolysis by thrombin was decreased by about 4000 after the NEM treatment.
On the other hand, adrenaline stimulated GTP hydrolysis in control membranes, with half-maximal and maximal activation at 1.5 /M and 30 /SM respectively. This stimulatory effect of adrenaline was decreased by about 90 o after NEM treatment. The potency of adrenaline seemed not to be changed by the NEM treatment, although, because of the small increase, an exact estimate cannot be given. Similar data with regard to the potency of thrombin and the decreased thrombin stimulation of GTP hydrolysis were obtained when the membranes were pretreated with 1 mM-NEM, as illustrated in Fig. 5 . At the high NEM concentration used (1 mM), only basal unstimulated GTP hydrolysis was further decreased, whereas the increase by thrombin was identical with that obtained with the 10-fold lower concentration of NEM.
Vol. 237 In order to determine whether after the NEM treatment the substrate characteristics of the thrombinstimulated GTP hydrolysis are changed, we studied the substrate kinetics of the GTPase reactions. Under all of the conditions studied, double-reciprocal plots of GTPase activity versus GTP concentration yielded straight lines (results not shown). In three separate experiments, the Km values for GTP in control membranes determined in the absence and presence of thrombin (0.1 unit/ml) were 0.31+ 0.04#m and 0.24 + 0.04 gtM respectively. In membranes pretreated with 0.1 mm, the corresponding Km values were 0.30 + 0.05 and 0.23 + 0.03 /LM respectively. The increases in Vmax. caused by thrombin were 15.9 + 2.1 and 10.0+1.2 pmol of Pi/min per mg of protein in control and NEM-treated membranes respectively.
The NEM resistance of thrombin stimulation of GTP hydrolysis by high-affinity GTPase in platelet membranes is similar to the NEM resistance of GTPase stimulation caused by PGE1, which via N. activates adenylate cyclase in these membranes (Jakobs et al., 1982; Lester et al., 1982) . In contrast with adrenaline-induced GTPase stimulation, the PGE1 stimulation of GTP hydrolysis is impaired by treatment of the membranes with cholera toxin (Aktories et al., 1983 ). Therefore we studied whether the thrombin stimulation ofGTP hydrolysis may be affected by cholera toxin. Treatment of platelet membranes for 10 min at 30°C with cholera toxin (100 ,g/ml) decreased the increase in GTPase activity caused by PGE1 (10 /uM) from 5.0 + 0.8 to 0.4 + 0.2 pmol of Pi/min per mg of protein (n = 3). In contrast, both adrenaline (100 gM)-and thrombin (0.1 unit/ml)-induced increases in GTP hydrolysis were unaffected by this cholera-toxin treatment (results not shown). at 25 'C. This reaction was stopped by adding 3 mmdithiothreitol. Thereafter, high-affinity GTPase activity was determined at the indicated concentrations of thrombin.
DISCUSSION
Guanine nucleotide-binding regulatory proteins are apparently involved in the coupling of membrane-bound hormone receptors to their effector systems, which catalyse the formation of intracellular second messengers (Rodbell, 1980) . Three of these proteins, namely N., N, and transducin, have been identified, purified and at least partially characterized with regard to their functions in the signal-transduction processes. Ns and Ni function as coupling components of stimulatory and inhibitory hormone receptors, respectively, to the adenylate cyclase, and transducin couples light-activated rhodopsin to a cyclic GMP phosphodiesterase in rod outer segments (Kuhn, 1980; Brandt et al., 1983; Gilman, 1984; Codina et al., 1984; Sunyer et al., 1984; Jakobs et al., 1985) . Another guanine nucleotide-binding protein (No) has been purified and biochemically characterized, but its function is not known so far (Sternweis & Robishaw, 1984; Neer et al., 1984) . All of these N proteins not only bind guanine nucleotides but also possess GTP-hydrolysing activity. On the other hand, evidence has now accumulated which suggests that the breakdown of membrane phosphoinositides caused by agonist-activated receptors also involves the coupling of a guanine nucleotide-binding regulatory protein (Litosch et al., 1985; Cockcroft & Gomperts, 1985; Smith et al., 1985; Lucas et al., 1985) . However, this protein has not been identified and purified so far. In some, but not all, cellular systems, studies with pertussis toxin, which has been shown to ADP-ribosylate and inactivate Ni (Ui 1986 al., 1984) , suggested that a protein similar to N1 is involved in these cell types in the receptor-induced phosphoinositide breakdown Nakamura & Ui, 1985; Volpi et al., 1985; Masters et al., 1985) .
In human platelets, thrombin is a potent and efficient activator of the phosphoinositide phosphodiesterase (Agranoff et al., 1983; Siess et al., 1984; Rittenhouse & Sasson, 1985) . Functional studies performed in permeabilized platelets suggested that this apparently receptor-mediated action of thrombin involves the coupling function of a guanine nucleotide-binding component (Haslam & Davidson, 1984a,b) . On the other hand, thrombin has been shown to induce adenylate cyclase inhibition in membranes of human platelets (Aktories & Jakobs, 1984) . Similar to the platelet adenylate cyclase inhibition caused by agonist-activated a2-adrenoceptors, the thrombin-induced inhibition apparently involves the coupling of the inhibitory guanine nucleotide-binding regulatory protein Ni.
Furthermore, similar to adrenaline, thrombin increases GTP hydrolysis in platelet membranes by activating a high-affinity GTPase(s) at the same concentrations as cause adenylate cyclase inhibition (Aktories & Jakobs, 1984) . Therefore, it was assumed that, similar to adrenaline, the thrombin-induced stimulation of GTP hydrolysis is an action of Ni.
However, as shown herein, the thrombin-induced stimulation of GTP hydrolysis in platelet membranes can be discriminated from the GTPase stimulation by adrenaline and from the thrombin-induced adenylate cyclase inhibition, both reactions involving Ni. Firstly, whereas adrenaline and thrombin at maximally effective concentrations were not additive with regard to adenylate cyclase inhibition, the stimulation of GTP hydrolysis caused by these agents was at least partially additive. Secondly, treatment of the platelet membranes with pertussis toxin blocked adrenaline-and thrombin-induced adenylate cyclase inhibition and adrenaline-induced GTPase stimulation, whereas thrombin-induced stimulation of GTP hydrolysis was rather resistant to this treatment. Thirdly, treatment of the platelet membranes with NEM abolished adrenaline-and thrombin-induced adenylate cyclase inhibition at very similar concentrations of the thiol reagent. However, the NEM treatment eliminated almost completely only the adrenaline-induced GTPase stimulation, whereas the thrombin-induced increase in GTP hydrolysis was only partially decreased by this treatment, even at high NEM concentrations. The NEM and pertussis-toxin treatment decreased the thrombin-induced increase in GTP hydrolysis by highaffinity GTPase to a similar extent of25-40 %. All ofthese data suggest that thrombin activates in membranes of human platelets two GTP-hydrolysing enzymes, one of them apparently being Ni. Since the partial NEM resistance of the thrombin-induced GTPase stimulation is similar to the NEM resistance of GTPase activity of N, stimulated by PGE1, we examined whether cholera-toxin treatment, which inhibits GTPase stimulation of N. (Cassel & Selinger, 1977) , would affect thrombin-induced GTPase stimulation. However, this was not the case, thus excluding the possibility that thrombin activates both N1 and Ns in platelet membranes.
After elimination of the N1 GTPase by NEM treatment, the remaining thrombin-induced stimulation of GTP hydrolysis exhibited characteristics quite similar to those observed in untreated membranes. Firstly, the concentrations of thrombin causing half-maximal stimulation of GTP hydrolysis were very similar, 0.004 and 0.006 unit/ml in control and NEM-treated membranes respectively. Secondly, the Km values of the thrombinstimulated GTPase enzymes were identical, 0.2-0.3 pM-GTP, in control and NEM-treated membranes. These data do not contradict the assumption that thrombin activates two GTP-hydrolysing enzymes. Firstly, when studied in intact membranes, the Ns-and Ni-related GTP-hydrolysing enzymes exhibit almost identical Km values in the range of0.1-0.3 pmM-GTP (Cassel & Selinger, 1976; Koski & Klee, 1981; Aktories & Jakobs, 1981) .
Furthermore, purified N. GTPase has a Km of about 0.3 4aM (Neer et al., 1984) . It is thus feasible that the unknown GTP-binding protein activated by thrombin exhibits a similar Km value for GTP to that of the purified NS, Ni and N. proteins. Secondly, the similarity in the potency of thrombin to activate the two apparently distinct GTP-hydrolysing enzymes may be due to the fact that the activated thrombin receptor interacts with the two N proteins with similar efficacy, or that there are two distinct receptor sites being activated by thrombin at very similar concentrations. At present, none of these possibilities can be excluded, since there are no specific tools to activate one or the other putative thrombin receptor or to inactivate selectively the GTPase activity apparently not related to Ni.
With regard to the possible function of the pertussistoxin-and NEM-resistant GTP-hydrolysing enzyme activated by thrombin, it is tempting to speculate that this component is involved in the coupling of thrombin receptors to the phosphoinositide phosphodiesterase. According to the data presented herein, this thrombin action should be insensitive to pertussis-toxin and NEM treatment, provided that these agents do not have additional, as yet unknown, effects on the phosphoinositide phosphodiesterase. Studies on the regulation of this signal transduction in platelet membranes are needed to understand the underlying coupling mechanisms.
